
Bhupendrasingh Harnamsingh Bhatia
About Bhupendrasingh Harnamsingh Bhatia
Data last updated:
Bhupendrasingh Harnamsingh Bhatia has 11 years in corporate governance. Holds Director role. Currently with 1 company, including Pragur Healthsciences Private Limited. Engaged in Healthcare. Contributes to corporate operations. The largest current company by reported revenue is Pragur Healthsciences Private Limited at ₹1.45 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 10 Aug 2015 | 2013 | ₹1.45 Cr (FY 2025) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Bhupendrasingh Harnamsingh Bhatia
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bhupendrasingh Harnamsingh Bhatia
Bhupendrasingh Harnamsingh Bhatia has 11 years in corporate governance. Holds Director role. Currently with 1 company, including Pragur Healthsciences Private Limited. Engaged in Healthcare. Contributes to corporate operations. The largest current company by reported revenue is Pragur Healthsciences Private Limited at ₹1.45 Cr (FY 2025).
Bhupendrasingh Harnamsingh Bhatia is associated with 1 company as Director, including Pragur Healthsciences Private Limited (₹1.45 Cr).
Bhupendrasingh Harnamsingh Bhatia has expertise in Healthcare.
Bhupendrasingh Harnamsingh Bhatia has 11 years in corporate governance.
By reported revenue, the largest current company of Bhupendrasingh Harnamsingh Bhatia is Pragur Healthsciences Private Limited, with revenue of ₹1.45 Cr (FY 2025).
Bhupendrasingh Harnamsingh Bhatia currently holds positions at 1 company: Pragur Healthsciences Private Limited (₹1.45 Cr).